Glucose metabolism in CKD patients is affected by increased insulin resistance, impaired counter-regulatory hormone response (cortisol, growth hormone), malnutrition, and variability in exposure to oral hypoglycemic agents and exogenous insulin. The gene discussed is GH1; the disease is chronic kidney disease.